Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia
Status unconfirmed
Conditions studied: Chronic Myeloid Leukemia
In brief
The objective of this study is to test the scale structure, reliability, validity and responsiveness to change of the QLQ-CML24 in conjuction with the QLQ-C30 for patients diagnosed with CML, and to investigate longitudinal relationship between satisfaction with information provision and QoL outcomes.
Key facts
- Study ID
- NCT03075969
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- People needed
- 337
- Starts
- 2017-08-03
- Expected to finish
- 2019-12-01
- Last updated by the study team
- 2019-03-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Above 18 years of age.
- Patient with confirmed diagnosis of Philadelphia chromosome positive and/or BCR-ABL positive chronic myeloid leukemia (CML).
- Written informed consent.
- Patients enrolled in investigational drug-trials or other type of clinical trials are also eligible.
You may not qualify if…
- Patients with a psychiatric condition or major cognitive impairment (as evaluated by their treating physician) that would hinder completion of self-reported health-related QoL questionnaires.
- Patients who are unable to speak and read the language of the questionnaire.
Where it is running
- Winship Cancer Institute of Emory University — Emory, Georgia, United States
- Innsbruck Medical University — Innsbruck, Austria
- Complexo Hospital de Clinicas da Universidade Federal do Parana — Paranã, Brazil
- Guangdong Medical University — Guangdong, China
- Universität Heidelberg — Heidelberg, Germany
- Baghdad Teaching Hospital — Baghdad, Iraq
- Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi — Ancona, Italy
- Azienda Ospedaliero-Universitaria Policlinico Consorziale — Bari, Italy
- Department of Oncology and Hematology, O.U. of Hematology, S. Orsola-Malpighi University Hospital, Bologna — Bologna, Italy
- Sezione di Ematologia e Trapianti Spedali Civili — Brescia, Italy
- CTMO - Ematologia - Ospedale Binaghi — Cagliari, Italy
- Divisione clinicizzata di Ematologia - Dipartimento di Scienze Mediche - Osp. Ferrarotto — Catania, Italy
- Clinica Ematologica - Dipartimento di Medicina Interna - IRCCS San Martino - IST — Genova, Italy
- Lecce ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE — Lecce, Italy
- U.O. Ematologia 1 - Centro Trapianti di Midollo - Ospedale Maggiore Milano — Milan, Italy
- Divisione di Ematologia - Dip. Di Medicina Clinica e Sperimentale & BRMA - Università Piemonte Orientale "Amedeo Avogato" — Novara, Italy
- Azienda Ospedaliera Universitaria - Policlinico Paolo Giaccone — Palermo, Italy
- U.O.C. di Ematologia e CTMO Az. Ospedaliero Universitaria Parma — Parma, Italy
- Div. di Ematologia IRCCS Policlinico S. Matteo — Pavia, Italy
- Dipartimento di Oncologia ed Ematologia - AUSL Ospedale G. da Saliceto — Piacenza, Italy
- Dipartimento Oncologico - Ospedale S.Maria delle Croci — Ravenna, Italy
- Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova — Reggio Emilia, Italy
- Clinica di Ematologia - Policlinico Umberto I- Università degli Studi "Sapienza" — Roma, Italy
- Divisione di Ematologia - Ospedale S.Eugenio — Roma, Italy
- Divisione Ematologia - Università Campus Bio-Medico — Roma, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.